Akathisia induced by concurrent use of mirogabalin and sulfamethoxazole-trimethoprim: a case report

Abstract Background Mirogabalin and trimethoprim-sulfamethoxazole (TMP/SMX) are frequently used as supportive purpose during and/or after chemotherapy. Mirogabalin is used to treat neuropathic pain, whereas TMP/SMX is used to prevent pneumocystis pneumonia (PCP) in patients who are immunocompromised...

Полное описание

Библиографические подробности

Главные авторы:	Takashi Nakashima, Kimitaka Suetsugu, Mina Nitta, Taichi Nagano, Makoto Yoshimitsu, Kenji Ishitsuka, Hideyuki Terazono
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMC 2026-04-01
Серии:	Journal of Pharmaceutical Health Care and Sciences
Предметы:	Mirogabalin Trimethoprim-sulfamethoxazole Akathisia Drug-drug interaction
Online-ссылка:	https://doi.org/10.1186/s40780-026-00578-y
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!